Frontlight ResearchEarly access
Trial site
Reggio Emilia
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer1 trial
- Myeloproliferative neoplasms1 trial
- Neuroendocrine tumours1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Running trials
Active, not recruiting
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026